» Articles » PMID: 22530087

Modified Hodge Test: A Simple and Effective Test for Detection of Carbapenemase Production

Overview
Date 2012 Apr 25
PMID 22530087
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Resistance among bacterial isolates is the leading cause of increased mortality and morbidity worldwide. Carbapenems once thought to be effective are becoming ineffective mostly due to the emergence of carbapenemase. This study was designed to determine in vitro efficacy of Modified Hodge test for detection of carbapenemase production in Gram negative rods.

Material And Methods: The study was done in the Department of Microbiology, Armed Forces Institute of Pathology Rawalpindi Pakistan from January 2010 to December 2010. A total of 200 Gram negative rods from different clinical samples were taken. Those isolates which showed intermediate or susceptible zones i.e 16mm-21mm on disc diffusion were included in the study. These isolates were then subjected to Modified Hodge test.

Result: Out of 200 isolates, 138 (69%) were positive for carbapenemase production by Modified Hodge test. Out of 138 MHT positive organisms, the frequency of E. coli was 38%, followed by Pseudomonas aeruginosa (30%), Klebsiella pneumoniae (17%), Acinetobacter baumannii (12%), Citrobacter diversus (2%) and Enterobacter agglomerans (1.4%).

Conclusion: Modified Hodge test is a simple test which can be performed in the routine lab for detection of carbapenemases in isolates showing intermediate or sensitive zone diameter on disc diffusion.

Citing Articles

Genomic nano-biosensor for rapid detection of the carbapenem-resistant gene in carbapenemase-producing bacteria.

Mayaka R, Alocilja E Nanoscale Adv. 2025; .

PMID: 40070438 PMC: 11891930. DOI: 10.1039/d4na00798k.


Phenotypic and molecular methods of carbapenemase detection: Can we break the chain and preserve the carbapenems?.

Kumar M, Bhalla G, Tandel K, Jain S, Singh G, Mahajan P Med J Armed Forces India. 2025; 80(6):657-666.

PMID: 39990540 PMC: 11842927. DOI: 10.1016/j.mjafi.2023.05.008.


Rapid Simultaneous Detection of the Clinically Relevant Carbapenemase Resistance Genes KPC, OXA48, VIM and NDM with the Newly Developed Ready-to-Use qPCR CarbaScan LyoBead.

Reinicke M, Diezel C, Teimoori S, Haase B, Monecke S, Ehricht R Int J Mol Sci. 2025; 26(3).

PMID: 39940986 PMC: 11818240. DOI: 10.3390/ijms26031218.


Comparison of Carbapenemases and Extended-Spectrum β-Lactamases and Resistance Phenotypes in Hospital- and Community-Acquired Isolates of from Croatia.

Car H, Dobric M, Pospisil M, Nad M, Luxner J, Zarfel G Microorganisms. 2024; 12(11).

PMID: 39597613 PMC: 11596078. DOI: 10.3390/microorganisms12112224.


Prevalence of Carbapenemase Production Among Klebsiella and Escherichia coli Isolated From Urinary Tract Infections.

Arumugam K, Karande G, Patil S Cureus. 2024; 16(10):e70918.

PMID: 39502962 PMC: 11537481. DOI: 10.7759/cureus.70918.


References
1.
Kumarasamy K, Toleman M, Walsh T, Bagaria J, Butt F, Balakrishnan R . Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010; 10(9):597-602. PMC: 2933358. DOI: 10.1016/S1473-3099(10)70143-2. View

2.
Chu Y, Afzal-Shah M, Houang E, Palepou M, LYON D, Woodford N . IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother. 2001; 45(3):710-4. PMC: 90361. DOI: 10.1128/AAC.45.3.710-714.2001. View

3.
Lomaestro B, Tobin E, Shang W, Gootz T . The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York. Clin Infect Dis. 2006; 43(3):e26-8. DOI: 10.1086/505598. View

4.
Bratu S, Brooks S, Burney S, Kochar S, Gupta J, Landman D . Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin Infect Dis. 2007; 44(7):972-5. DOI: 10.1086/512370. View

5.
Iyobe S, Kusadokoro H, Ozaki J, Matsumura N, Minami S, Haruta S . Amino acid substitutions in a variant of IMP-1 metallo-beta-lactamase. Antimicrob Agents Chemother. 2000; 44(8):2023-7. PMC: 90008. DOI: 10.1128/AAC.44.8.2023-2027.2000. View